Lanean...
Evaluating biomarkers for prognostic enrichment of clinical trials
BACKGROUND/AIMS: A potential use of biomarkers is to assist in prognostic enrichment of clinical trials, where only patients at relatively higher risk for an outcome of interest are eligible for the trial. We investigated methods for evaluating biomarkers for prognostic enrichment. METHODS: We ident...
Gorde:
| Argitaratua izan da: | Clin Trials |
|---|---|
| Egile Nagusiak: | , , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2017
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5714681/ https://ncbi.nlm.nih.gov/pubmed/28795578 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1740774517723588 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|